GLP‑1: protein, strength, genes

Glucagon-like peptide 1 drugs work partly by slowing stomach emptying and dialing down hunger, so many people eat much less within weeks of starting semaglutide or tirzepatide. That is great for fat loss, but a body that suddenly gets less food also gets less protein unless meals are planned on purpose. (nature.com) (today.com) Protein is the raw material your body uses to repair muscle, the same way a contractor needs lumber to keep a house standing. TODAY’s diet coverage notes that not getting enough protein can lead to muscle loss, thinning hair, brittle nails, weak bones, and slower recovery after illness or injury. (today.com) The muscle issue is not theoretical, because the big semaglutide trial enrolled 1,961 adults and showed average body weight fell 14.9% by week 68. When weight comes off that fast, clinicians have been warning that some of the loss can come from lean tissue, not just body fat. (nejm.org) (nature.com) That is why resistance exercise matters more on these drugs than it does in a normal casual diet. Indian Express summarized the current advice in one simple line: if muscles are not being challenged, the body has less reason to keep them. (indianexpress.com) Resistance exercise just means making a muscle push against load, like standing up from a chair slowly, doing wall push-ups, stepping onto a stair, or pulling a resistance band. The Indian Express piece says two to three sessions a week of about 20 to 30 minutes can be enough to give that “keep this tissue” signal without exhausting someone whose calorie intake is lower than usual. (indianexpress.com) Food has to match the training, because lifting without protein is like sending bricklayers to a site with no bricks. TODAY’s reporting says protein needs vary by age, weight, sex, and activity, but dietitians consistently point people toward compact options like eggs, Greek yogurt, chicken, fish, cottage cheese, tofu, lentils, and protein-rich snacks that are easier to finish when appetite is blunted. (today.com 1) (today.com 2) The other practical problem is side effects, because these drugs can make a large, greasy, or high-fiber meal sit in the stomach longer and feel awful. In TODAY’s June 26, 2025 report, dietitian Jennifer Lynn-Pullman said nausea and vomiting were worse when portions were too big or foods were too fatty, so she shifted toward smaller meals, soups, smoothies, and crackers during rough stretches. (today.com) Now the science is moving past one-size-fits-all advice and into genetics. A Nature study published on April 8, 2026 analyzed 27,885 people taking glucagon-like peptide 1 drugs and found that a variant in the GLP1R gene was linked to stronger weight-loss response, with about 0.76 kilograms of extra loss per copy of the effect allele. (nature.com) The same study found gene links to nausea and vomiting risk, and one signal in the GIPR gene appeared only in people using tirzepatide, which hits both the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide pathways. In plain English, two people can take similar drugs, follow similar habits, and still get different results partly because the receptors those drugs target are built a little differently. (nature.com 1) (nature.com 2) So the new playbook is getting clearer: use the drug, but also protect the engine. That means smaller meals that still contain real protein, short strength sessions repeated every week, and eventually more personalized prescribing as genetic data gets good enough to flag who is likely to lose more weight and who is more likely to get side effects. (indianexpress.com) (nature.com)